期刊文献+

化疗对肺癌患者手术的影响及外科处理特点 被引量:3

Effects of chemotherapy on operation for lung cancer
暂未订购
导出
摘要 目的 :探讨化疗对肺癌患者手术的具体影响。方法 :随机将 10 0例肺癌患者分为两组 :①术前化疗组 ,手术前先行化疗 ,再予手术 ,共 5 9例 ;②术后化疗组 ,先行手术 ,术后再予化疗 ,共 4 1例。绝大多数病例接受MVP方案化疗 ,周期数 1~ 6不等。术中观察两组患者胸内组织结构的变化。记录患者手术时间、术中失血量及术后第一日引流量等指标 ,运用SPSS软件分析之。结果 :①观察显示 :术前化疗导致肺癌患者胸膜、肿瘤周围组织、淋巴结纤维化 ,以肺动脉外膜及其附近组织最为明显 ,因而手术风险和难度明显增加。组织纤维化程度与化疗周期数有一定相关性。②术前化疗组手术时间略长 (P >0 0 5 ) ,术中失血量略多 (P >0 0 5 ) ,但均无统计学意义。③术后引流量两组无差异。结论 :化疗可增加肺癌患者手术的风险。针对纤维化 ,术中更细致的止血是减少术中 ,术后失血的主要手段。充足的化疗间隔 。 Purpose:To investigate the effects of chemotherapy on the patient's operation for lung cancer.Methods:One hundred patients were randomized into two groups. ①Preoperative chemotherapy group, the patients accepted chemotherapy first, then underwent operation, 59 cases;②postoperative chemotherapy group, the patients accepted the chemotherapy after operation, 41 cases. Most of the patients accepted the MVP chemotherapy regimen (1-6 course). All patients underwent operation of lobectomy or pneumonectomy. During the operation, the change of thorax structure was observed. Some indexes, which include operation time, blood loss during operation and postoperative drainage volume of first day, were recorded. The data were analysed with SPSS software.Results:①It is indicated that preoperative chemotherapy induce thoracic tissue fibrosis, which include pleura, the tissue around tumor and lymph nodes. The tissue fibrosis of pulmonary artery was most notable, which increase the risk and difficulty of operation .The serious grade of tissue fibrossis was related to the courses of chemotherapy. ②The operation time of preoperative chemotherapy group was longer than that of postoperative chemotherapy group ( P <0 05).③The blood loss of preoperative chemotherapy group was much more than that of postoperative chemotherapy group ( P >0 05).④There was no significant difference in postoperative drainage volume in the two groups.Conclusions:①Chemotherapy increases the patients′ operation risks for lung cancer;②Fibrosis is an underlying risk factor for blood loss, it is necessary to pay more attention to careful hemostasia during the operation. ③To decrease the risks of postoperative complication, sufficient interval after chemotherapy, preoperative preparation and proper management after operation are the key factors.
作者 周允中
出处 《中国癌症杂志》 CAS CSCD 2003年第5期408-410,共3页 China Oncology
关键词 肺癌 手术 化疗 外科处理 lung cancer operation chemotherapy
  • 相关文献

参考文献4

  • 1De-Leyn P, Vansteenkiste J, Deneffe G, et al. Result of induction chemotherapy followed by surgery in patients with stage Ⅲ a N2 NSCLC: importance of pre-treatment mediastinoscopy[J]. Eur J Cardiothorac Surg.1999 .15(5):608-614.
  • 2Mathisen D J, Wain JC, Wright C, et al. Assessment of preoperative accelerated radiotherapy and chemotherapy in stage Ⅲa (N2) NSCLC[J]. J Thorac Cardiovasc Surg, 1996,111(1) :123-131.
  • 3Sonett JR, Krasna MJ, Suntharalingam M, et al. Safe pulmonary resection after chemotherapy and high-dose thoracic radiation[ J]. Ann Thorac SUrg, 1999,68(2) :316-320.
  • 4Yamamoto R, Tada H, Kishi A, et al. Effects of preoperative chemotherapy and radiation therapy on human bronchial blood flow[ J ]. J Thorac Cardiovasc Surg ,2000,119(5 ) :939-945.

同被引文献11

  • 1Slmsova I. The position of neoadjuvant chemotherapy in the treatment of non - small - cell lung carcinoma[J]. Vnitr Lek,20(17. 53(6) :715 -723.
  • 2Gkiozos I,Charpidou A,Syrigos K. Developments in the treatment of non - small - cell lung cancer[ J]. Anticancer Res,2007,27(4C) :2823 -2827.
  • 3Paget Brown A, Kattwinkel J, Rodgers BM, et al. The use of octreotide to treat congenital chylothorax. J Pediatr Surg. 2006. 41:845 - 847.
  • 4Tar V, Yilm~cr MM. Guven B, et aL Octreotide treatment for chylothorax after congenital heart surgery [ J ]. J Card Surg,2009,24 (5) :570 - 57 I.
  • 5Mahmoud SA, Abdel - Elah K, Eldesoky AH, et all Oetreotide can control lyraphorrhea after axiUary node dissection in mastectomy operations. Breast J, 2007,13 (1) :108 -109.
  • 6Lang A, Saldanini E, Fidder HH. et aL Somatostatin inhibits pro - inflam- matory eytokine secretion from rat hepatic stellatc cells [ J ]. Liver Int, 2005,25 (4) :808 - 816.
  • 7De-Leynp,Vansteenkiste J,Deneffe G,et al.Result of induction chemotherapy followed by importance of pre-treatment mediastio:copy [J].Eur J Cardiothorac Surg,1999,15(5):608-614.
  • 8Mathisen DJ,Wain Jc,Wright C,et al.Assessment of preoperative accelerated radiotherapy and chemotherapy in stage Ⅲa(N2) NSCLC [J].J Thora Curdiovasc Surg,1996(1):123-131.
  • 9De Leyn P, Vansteenkiste J, Deneffe G, et al. Result of induction chemotherapy followed by surgery in patients with stage Ⅲ a N2 NSCLC;importance of pre- treatment mediastinoscopy. Eur J Cardiothorac Surg, 1999,15(5): 608
  • 10Mathisen DJ, Wain JC, Wright C, et al. Assessment of preoperative accelerated radiotherapy and chemotherapy in stage Ⅲ a (N2) NSCLC. J Tnorac Cardiovasc Surg, 1996,111(1):123

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部